DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / L•••••••• C•••••• M••••••••• C••• L••
L•••••••• C•••••• M••••••••• C••• L••
L•••••••• Capital is a healthcare venture capital firm that invests in transformative healthcare companies to unlock value and enable growth.
name or self-description says syndicate platform
Importance
39
elevated
Active deployment
29
moderate
Emerging
0
low
Completeness
88
high
Freshness
98
high
Research priority
10
low
Identity and regulatory footprint
- Headquarters
- Menlo Park, CAadviserinfo.sec.gov
- Office address
- 2740 SAND HILL ROAD, 2ND FLOOR, Menlo Park, CA, 94025adviserinfo.sec.gov
- Business phone
- 650-854-5700adviserinfo.sec.gov
- Website
- l•••••••••.com
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Aug 21, 2026
- Private funds reported
- 6 (6 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $2.4Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $2.4Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 27
- business phone
- 650-854-5700adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, hardware, agtech
- Stages
- early
- Geography
- boston, global, north america, north carolina, silicon valley
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- syndicate platform
Observed (from deals on record)
Stage at participation
series a 100%
Stage at first entry
series a 100%
Sectors
Biotechnology 100%
lead rate 100%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
6 reported, 3 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| L•••••••• 1•••• E•••• L••• | Fund | 2025 form d first sale | Newly closed | unknown | unknown | $100M of $100M | Nov 13, 2025 |
| L•••••••• V•••••• P••••••• V• L••• | Fund | 2022 form d first sale | Active deployment | $336M Mar 29, 2024 | 50 | $207M of $600M | Jul 20, 2023 |
| L•••••••• P•••• F•••• L••• | Fund | 2022 adv first reported | Active deployment | $142M Mar 29, 2024 | 35 | $0 of $130M | Jun 17, 2021 |
| L•••••••• V•••••• P••••••• I•• L••• | Fund | 2020 adv first reported | Mature | $639M Mar 29, 2024 | 80 | $0 of $550M | Sep 20, 2019 |
| L•••••••• V•••••• P••••••• I••• L••• | Fund | 2016 form d first sale | Harvest | $459M Mar 29, 2024 | 70 | $0 of $525M | May 10, 2016 |
| L•••••••• V•••••• P••••••• I•• L••• | Fund | 2011 form d first sale | Harvest | $95.2M Mar 29, 2024 | 50 | $385M of $385M | Oct 23, 2012 |
| L•••••••• P•••• F••• I•• L••• | Fund | 2023 adv first reported | Wound down | $49.0M Mar 30, 2023 | 7 | unknown | unknown |
| L•••••••• C•••••• A••••••••• L••• | Fund | unknown | Wound down | $0 Mar 13, 2020 | 0 | unknown | unknown |
| L•••••••• V•••••• P•••••••• L••• | Fund | unknown | Wound down | $0 Mar 13, 2020 | 0 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 0 departed
J••••• P•••••••• T•••••••••
Managing partnerManaging Member Of L•••••••• C•••••• M••••••••• C••• L•• · since Aug 1, 2006
P•••••• G••••• E••••••
Managing partnerManaging Member Of L•••••••• C•••••• M••••••••• C••• L•• · since Aug 1, 2006
M•••••• B•••••
PartnerManaging Director
C•••••• E•••••••• H••••
Platform and operationsManaging Director / Chief Financial Officer Of L•••••••• C•••••• M••••••••• C••• L•• · since Mar 1, 2012
C•••••••• B••••• O•••••••
Platform and operationsChief Compliance Officer Of L•••••••• C•••••• M••••••••• C••• L•• · since Sep 1, 2021
Investments on record
2 edges, 2 companies, 2 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| V••••••• S•••••••• I••• | Series A · Series A | lead | M•••••• B••••• (confirmed) | $30.0M | unknown | Jan 9, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
| Z•••• B••••••••• I••• | board seat | unknown · board | P•••••• G••••• E•••••• (strongly supported) | unknown | unknown | May 14, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
2 relationships from shared deals, counted for the whole firm
Limited partners
7 disclosed
- T•••••••• R••••••••• S••••• o• t•• S•••• o• I••••••• amount undisclosed trsil.org
- C••••••• P••••• E••••••••• R••••••••• A••••••••• in L•••••••• V•••••• P•••••••• L••• $15.0M content.copera.org
- C••••••• P••••• E••••••••• R••••••••• A••••••••• in L•••••••• P•••• F•••• L••• $30.0M content.copera.org
- C••••••• P••••• E••••••••• R••••••••• A••••••••• in L•••••••• V•••••• P••••••• I••• L••• $36.0M content.copera.org
- C••••••• P••••• E••••••••• R••••••••• A••••••••• in L•••••••• V•••••• P••••••• I•• L••• $50.0M content.copera.org
- C••••••• P••••• E••••••••• R••••••••• A••••••••• in L•••••••• V•••••• P••••••• I•• L••• $25.0M content.copera.org
- L•• A•••••• C••• E••••••••• R••••••••• S••••• in L•••••••• V•••••• P••••••• I••• L••• amount undisclosed lacers.org
Timeline
14 dated events
- Jun 2, 2025I••••••• TRS lists L•••••••• Capital Management among its private equity managers
- Mar 29, 2024L•••••••• P•••• F••• I•• L••• no longer reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L••Fund no longer reportedFundsInferenceL•••••••• P•••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2023L•••••••• V•••••• P••••••• V• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $190,000,000Fund first reported on Form ADVFundsFactL•••••••• V•••••• P••••••• V• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2023L•••••••• P•••• F••• I•• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $49,000,000Fund first reported on Form ADVFundsFactL•••••••• P•••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2022L•••••••• P•••• F•••• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $148,784,000Fund first reported on Form ADVFundsFactL•••••••• P•••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Sep 1, 2021C•••••••• B••••• O••••••• joined Schedule A of L•••••••• C•••••• M••••••••• C••• L•• as Chief Compliance Officer Of L•••••••• C•••••• M••••••••• C••• L••
- Mar 24, 2021L•••••••• V•••••• P•••••••• L••• no longer reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L••Fund no longer reportedFundsInferenceL•••••••• V•••••• P•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 24, 2021L•••••••• C•••••• A••••••••• L••• no longer reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L••Fund no longer reportedFundsInferenceL•••••••• C•••••• A••••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 13, 2020L•••••••• V•••••• P••••••• I•• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $574,592,000Fund first reported on Form ADVFundsFactL•••••••• V•••••• P••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2017L•••••••• V•••••• P••••••• I••• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $523,693,000Fund first reported on Form ADVFundsFactL•••••••• V•••••• P••••••• I••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L•••••••• C•••••• M••••••••• C••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L•••••••• V•••••• P••••••• I•• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $336,611,675Fund first reported on Form ADVFundsFactL•••••••• V•••••• P••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L•••••••• C•••••• A••••••••• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $9,203,000Fund first reported on Form ADVFundsFactL•••••••• C•••••• A••••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012L•••••••• V•••••• P•••••••• L••• first reported on Form ADV by L•••••••• C•••••• M••••••••• C••• L•• (Venture Capital Fund), GAV $459,168,000Fund first reported on Form ADVFundsFactL•••••••• V•••••• P•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Syndicate platform (probable, 80%, cls-1)name or self-description says syndicate platform
Evidence
60 observations from 3 sources